Renal replacement therapy in critically ill patients

Hong Kong Medical Journal

Volumn 15, Issue 2, 2009, Pages 122-129

  Leung, Anne K H ^a   Yan, W W ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Critical illness; Kidney failure, acute; Renal dialysis; Renal replacement therapy; Treatment outcome

Indexed keywords

CITRATE SODIUM; CITRIC ACID; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NAFAMSTAT; PROSTAGLANDIN; SERINE PROTEINASE INHIBITOR;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; FORWARD HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPOCALCEMIA; HYPOTENSION; LOADING DRUG DOSE; MORTALITY; MUSCLE CRAMP; NAUSEA; PARESTHESIA; PROGNOSIS; QT PROLONGATION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TETANY; CRITICAL ILLNESS; INTENSIVE CARE UNIT; REVIEW;

CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY;

EID: 65449146302     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Uchino S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006;12:538-543
2. Kellum JA, Ronco C, Mehta R, Bellomo R. Consensus development in acute renal failure: The Acute Dialysis Quality Initiative. Curr Opin Crit Care 2005;11:527-532 (Pubitemid 41697322)
3. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
4. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006;10:R73.
5. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettilä V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006;81:542-546
6. Hoste EA, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 2006;12:531-537
7. Lopes JA, Jorge S, Resina C, et al. Prognostic utility of RIFLE for acute renal failure in patients with sepsis. Crit Care 2007;11:408. (Pubitemid 46736805)
8. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol 1995;6:1319-1328
9. Ronco C, Bellomo R, Kellum JA. Continuous renal replacement therapy: opinions and evidence. Adv Ren Replace Ther 2002;9:229-244
10. Teschan PE, Baxter CR, O'Brien TF, Freyhof JN, Hall WH. Prophylactic hemodialysis in the treatment of acute renal failure. Ann Intern Med 1960;53:992-1016.
11. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D. Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis. Kidney Int 1972;1:190-196
12. Palevsky PM. Dialysis modality and dosing strategy in acute renal failure. Semin Dial 2006;19:165-170
13. Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 1975;15:1056-1063
14. Bent P, Tan HK, Bellomo R, et al. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-837 (Pubitemid 32210386)
15. Demirkilic U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004;19:17-20. (Pubitemid 38175127)
16. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002;30:2205-2211
17. Guideline 4. Minimally adequate hemodialysis. Clinical practice guidelines for hemodialysis adequacy, Update 2006. National Kidney Foundation Dialysis Outcomes Quality Initiative. National Kidney Foundation website: http://www.kidney.org/professionals/kdoqi/guideline-upHD-PD-VA/index.htm. Accessed 27 Aug 2007.
18. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
19. Guideline 2. Methods for measuring and expressing the hemodialysis dose. Clinical practice guidelines for hemodialysis adequacy, Update 2006. National Kidney Foundation Dialysis Outcomes Quality Initiative. National Kidney Foundation website: http://www.kidney.org/professionals/kdoqi/guideline-upHD-PD- VA/index.htm. Accessed 27 Aug 2007.
20. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volumeKt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-1213
21. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006
22. Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs 2003;27:815-820
23. Sigler MH. Transport characteristics of the slow therapies: implications for achieving adequacy of dialysis in acute renal failure. Adv Ren Replace Ther 1997;4:68-80.
24. Pisitkun T, Tiranathanagul K, Poulin S, et al. A practical tool for determining the adequacy of renal replacement therapy in acute renal failure patients. Contrib Nephrol 2004;144:329-349
25. Ricci Z, Salvatori G, Bonello M, et al. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005;9:R266-73.
26. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Curr Opin Nephrol Hypertens 2001;10:755-761
27. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587
28. Piccinni P, Dan M, Barbacini S, et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80-86
29. Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006;368:379-385
30. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006;70:1312-1317
31. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
32. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008;19:1233-1238
33. Bellomo R. RCT of normal vs. augmented level of renal replacement therapy in ICU-RENAL. The George Institute for International Health website: http://www.thegeorgeinstitute.org/research/renal/studies/rct-of-normal-vs. -augmented-level-of-renal-replacement-therapy-in-icu-renal.cfm. Accessed 23 Aug 2007.
34. Honore P. Haemofiltration study: IVORE (hIgh VOlume in Intensive Care). ClinicalTrials.gov website: http://clinicaltrials.gov/ct/show/NCT00241228. Accessed 23 Aug 2007.
35. Monti G, Herrera M, Kindgen-Milles D, et al. The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI). Contrib Nephrol 2007;156:434-443
36. Uchino S, Bellomo R, Kellum JA, et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 2007;30:281-292
37. Ward DM. The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther 1997;4:160-173
38. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey: The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563-1570
39. Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 1996;27:519-524
40. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-752
41. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981
42. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-374
43. Palsson R, Laliberte KA, Niles JL. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration. Clin Nephrol 2006;65:34-42.
44. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005;20:155-161
45. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265
46. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367
47. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 2007;11:218.
48. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006;32:188-202.